Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 14, 2026, 8:32 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 961–984 of 1,098 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Physiological Clear all

Conditions: Antidepressant Induced Sexual Dysfunction
Interventions: Maca Root, Placebo; Drug
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years to 80 Years · Female only
Enrollment: 45 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2010
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Peyronie Disease, Erectile Dysfunction
Interventions: Collagenase Clostridium Histolyticum, Storz Duolith LiSWT; Drug · Device
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older · Male only
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Healthy Volunteers
Interventions: Placebo, Vaporized THC alone, Vaporized CBD alone, Vaporized CBD with THC; Drug
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years to 50 Years
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Reproductive Physiological Processes, Pediatrics, Adolescent Health, Adolescent Development
Interventions: Not listed
Lead sponsor: National Institute of Environmental Health Sciences (NIEHS); NIH
Eligibility: 8 Years to 65 Years · Female only
Enrollment: 400 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2029
U.S. locations: 1
States / cities: Research Triangle Park, North Carolina

Conditions: Critical Illness, Physiological Stress, Delirium, Sleep Deprivation
Interventions: Sound reduction, Sound masking; Device
Lead sponsor: Brian Gehlbach; Other
Eligibility: 18 Years to 99 Years
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2024
U.S. locations: 1
States / cities: Iowa City, Iowa

Conditions: Breast Cancer Female, Sexual Dysfunction
Interventions: Educational video series; Other
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years to 99 Years · Female only
Enrollment: 32 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: ER-Positive HER2-Negative Breast Cancer
Interventions: AZD9833, Anastrozole, Anastrozole placebo, AZD9833 placebo, Palbociclib, Luteinizing hormone-releasing hormone (LHRH) agonist; Drug
Lead sponsor: AstraZeneca; Industry
Eligibility: 18 Years to 130 Years
Enrollment: 1,371 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2029
U.S. locations: 30
States / cities: Mobile, Alabama • Springdale, Arkansas • Harbor City, California + 25 more

Conditions: Breast Cancer
Interventions: Doxorubicin followed by Paclitaxel, Paclitaxel followed by Doxorubicin; Other
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years to 120 Years · Female only
Enrollment: 62 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2000
U.S. locations: 2
States / cities: Boston, Massachusetts

Conditions: Erectile Dysfunction, Diabetes Mellitus, Type 2
Interventions: sildenafil, placebo; Drug
Lead sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc.; Industry
Eligibility: 35 Years to 70 Years · Male only
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2002 – 2004
U.S. locations: 28
States / cities: Huntsville, Alabama • Phoenix, Arizona • Beverly Hills, California + 21 more

Conditions: Coronary Artery Disease
Interventions: Not listed
Lead sponsor: National Heart, Lung, and Blood Institute (NHLBI); NIH
Eligibility: 21 Years and older
Enrollment: 34 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2010
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Female Athletes, Healthy Women
Interventions: Not listed
Lead sponsor: PepsiCo Global R&D; Industry
Eligibility: 16 Years to 45 Years · Female only
Enrollment: 50 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Bradenton, Florida

Conditions: Alzheimer Disease
Interventions: Blood draws, Hyperinsulinemic Euglycemic Clamp Technique Insulin Sensitivity test, Resting Metabolic Rate (RMR); Other
Lead sponsor: Pennington Biomedical Research Center; Other
Eligibility: 65 Years to 75 Years · Male only
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Baton Rouge, Louisiana

Conditions: Cardiovascular Diseases, Hypertension, Cognitive Decline, Diet, Healthy
Interventions: XO Genius; Dietary Supplement
Lead sponsor: The University of Texas at Arlington; Other
Eligibility: 18 Years to 50 Years
Enrollment: 6 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Arlington, Texas

Conditions: Vaginal Atrophy, Sexual Dysfunction, Vaginal Dryness, Dyspareunia
Interventions: Hybrid Fractional Laser; Device
Lead sponsor: Sciton; Industry
Eligibility: 40 Years to 70 Years · Female only
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2021
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Pain, Procedural
Interventions: Lidocaine; Drug
Lead sponsor: Virginia Commonwealth University; Other
Eligibility: Up to 6 Years
Enrollment: 59 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2024
U.S. locations: 1
States / cities: Richmond, Virginia

Conditions: Overactive Bladder
Interventions: Botulinum toxin and cineMRI-UDS; Other
Lead sponsor: Cedars-Sinai Medical Center; Other
Eligibility: 21 Years and older · Female only
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2025
U.S. locations: 1
States / cities: Beverly Hills, California

Conditions: Behavior, Anxiety
Interventions: Placebo then intranasal oxytocin, Intranasal oxytocin then placebo; Drug
Lead sponsor: MacDonald, Kai, M.D.; Individual
Eligibility: 18 Years to 65 Years · Male only
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2012
U.S. locations: 1
States / cities: San Diego, California

Conditions: Inflammatory Bowel Diseases
Interventions: Whoop strap 3.0; Device
Lead sponsor: Milton S. Hershey Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 8 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: Hershey, Pennsylvania

Conditions: Vulvodynia, Dyspareunia, Breast Cancer, Menopause
Interventions: Topical liquid lidocaine, Topical saline; Drug
Lead sponsor: OHSU Knight Cancer Institute; Other
Eligibility: 18 Years to 70 Years · Female only
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2013
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Erectile Dysfunction
Interventions: delivery system; Other
Lead sponsor: Pfizer; Industry
Eligibility: 40 Years to 70 Years · Male only
Enrollment: 48 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011
U.S. locations: 2
States / cities: Overland Park, Kansas

Conditions: Erectile Dysfunction
Interventions: Udenafil 50 mg, Udenafil 100 mg, Udenafil 150 mg, Placebo Matching 50 mg Udenafil, Placebo Matching 100 mg Udenafil, Placebo Matching 150 mg Udenafil; Drug
Lead sponsor: Warner Chilcott; Industry
Eligibility: 19 Years and older · Male only
Enrollment: 1,027 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2011
U.S. locations: 72
States / cities: Birmingham, Alabama • Homewood, Alabama • Huntsville, Alabama + 65 more

Conditions: Parent-Child Relations, Development, Infant, Parenting, Development, Child
Interventions: Circle of Security Parenting, Little Talks; Behavioral
Lead sponsor: University of Maryland, College Park; Other
Eligibility: 8 Months and older
Enrollment: 249 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2027
U.S. locations: 2
States / cities: College Park, Maryland • Bethlehem, Pennsylvania

Conditions: Stress, Psychological, Stress, Physiological, Anxiety, Pain Perception
Interventions: Use of Virtual Reality App; Behavioral
Lead sponsor: Stanford University; Other
Eligibility: 10 Years to 20 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Stanford, California

Conditions: Sleep
Interventions: Orgasmic Meditation; Behavioral
Lead sponsor: Institute of OM Foundation; Industry
Eligibility: 18 Years and older
Enrollment: 41 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Santa Rosa, California

Search by objective public record fields.

Study of Maca Root for the Treatment of Antidepressant-Induced Sexual Dysfunction in Females

Concurrent Low Intensity Shockwave Therapy on Collagenase Clostridium Histolyticum for Peyronie's Disease

Behavioral and Physiological Effects of THC and CBD

Reproductive Axis Maturation in the Early Post-Menarchal Years

Trial to Evaluate the Effects of Sound Modulation on Critically Ill Patients

Sexual Health and Breast Cancer: Developing Appropriate Education for Women Going Through Treatment

A Comparative Study of AZD9833 Plus Palbociclib Versus Anastrozole Plus Palbociclib in Patients With ER-Positive HER2 Negative Breast Cancer Who Have Not Received Any Systemic Treatment for Advanced Disease

Neoadjuvant Chemotherapy Using Doxorubicin and Paclitaxel in Treating Women With Large Breast Cancer

A Multicenter, Double-blind Study to Evaluate the Effect of Pretreatment With a Daily Dose of Sildenafil on the As-Needed Efficacy of Viagra in Men With Erectile Dysfunction and Type 2 Diabetes

Validation of MRI Measurement of Cardiac Blood Flow

A Descriptive Analysis of the Physiological and Behavioral Profiles of Elite Female Athletes

Effect of Physiologic Insulin Administration on Cognition

The Impact of KETO5 XOGenius Beverage on Markers of Physiological and Neurocognitive Health

Randomized, Controlled Trial With Hybrid Fractional Laser

The Effect of Local Anesthesia on Control of Intraoperative Physiologic Parameters and Post Operative Comfort

The Use of cineMRI to Evaluate Botox in Patients With Medication Refractory Overactive Bladder

Effects of Oxytocin on Behavior and Physiology in a Psychotherapy Setting

Remote Physiologic Monitoring to Detect Inflammatory Bowel Disease (IBD) Flares: A Feasibility Study

Therapy to Prevent Sexual Pain in Breast Cancer Survivors

Caverject User Study

Treatment of Erectile Dysfunction - Long Term Safety and Efficacy

Hands and Hearts Together

Stress Inoculation Through Virtual Reality in the Pediatric Electrophysiology Laboratory

Orgasmic Meditation and Sleep Quality